Clinical Trial Update: OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating optimized antiviral therapy for COVID-19 in immunocompromised patients; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Snippet

Sponsor: Calmy Alexandra | Conditions: COVID-19, Immunodeficiency | Phase 2 | Status: RECRUITING